# Levalbuterol HCL Solution

Notice 59a85b0521a249db969991decb9fa913 (solicitation SPE2D221R0116) from DEPT OF DEFENSE, DLA TROOP SUPPORT, posted 2023-08-23, responses due -. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | 59a85b0521a249db969991decb9fa913 |
| Solicitation number | SPE2D221R0116 |
| Type | Award Notice |
| Agency | DEPT OF DEFENSE |
| Sub-tier | DEFENSE LOGISTICS AGENCY |
| Office | DLA TROOP SUPPORT |
| Posted | 2023-08-23T16:52:34.000Z |
| Response deadline (UTC) | - |
| Set-aside | - |
| NAICS | 325412 |
| PSC | 6505 |
| Place of performance | Cheshire, GB-ENG, GBR |
| Award | SPE2D222D0146 to Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA, $5,687,207 |

## Description

P00003 SPE2D222D0146 Modification to incorporate Drug Supply Chain Security Act language into solication for subject contract. P00002 SPE2D222D0146 Modification to Invoke Option Year 1. P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) Contract Award for Leavalbuterol HCL Solution SPE2D222D0146

## Sources

- View on SAM.gov: https://sam.gov/opp/59a85b0521a249db969991decb9fa913/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Levalbuterol HCL Solution, SAM.gov contract opportunity 59a85b0521a249db969991decb9fa913." samgovapi.io, https://samgovapi.io/opportunity/59a85b0521a249db969991decb9fa913, data as of 2026-11-14. Primary record: https://sam.gov/opp/59a85b0521a249db969991decb9fa913/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/59a85b0521a249db969991decb9fa913
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot